Last reviewed · How we verify
AloCelyvir
At a glance
| Generic name | AloCelyvir |
|---|---|
| Sponsor | José María Piulats Rodríguez |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy (PHASE1, PHASE2)
- Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AloCelyvir CI brief — competitive landscape report
- AloCelyvir updates RSS · CI watch RSS
- José María Piulats Rodríguez portfolio CI